Drug Type Hormone |
Synonyms Humalog Cart, Humalog Miriopen, INSULIN LISPRO RECOMBINANT + [25] |
Target |
Action agonists |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date European Union (30 Apr 1996), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus | Liechtenstein | 30 Apr 1996 | |
Diabetes Mellitus | European Union | 30 Apr 1996 | |
Diabetes Mellitus | Norway | 30 Apr 1996 | |
Diabetes Mellitus | Iceland | 30 Apr 1996 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Noninsulin-Dependent, Type 4 | Phase 1 | Brazil | 01 Nov 2010 | |
Diabetes Mellitus, Noninsulin-Dependent, Type 4 | Phase 1 | Mexico | 01 Nov 2010 | |
Diabetes Mellitus, Noninsulin-Dependent, Type 4 | Phase 1 | Belgium | 01 Nov 2010 | |
Diabetes Mellitus, Noninsulin-Dependent, Type 4 | Phase 1 | Canada | 01 Nov 2010 | |
Diabetes Mellitus, Noninsulin-Dependent, Type 4 | Phase 1 | Sweden | 01 Nov 2010 | |
Diabetes Mellitus, Noninsulin-Dependent, Type 4 | Phase 1 | Greece | 01 Nov 2010 | |
Diabetes Mellitus, Noninsulin-Dependent, Type 4 | Phase 1 | Australia | 01 Nov 2010 | |
Diabetes Mellitus, Noninsulin-Dependent, Type 4 | Phase 1 | Puerto Rico | 01 Nov 2010 | |
Diabetes Mellitus, Type 1 | Phase 1 | China | 01 Mar 2005 | |
Diabetes Mellitus, Type 2 | Phase 1 | Mexico | 01 Nov 2002 |
Phase 3 | 730 | (500 U/mL - Insulin Efsitora) | gfyvuendmf(phruqwlcox) = kolugmlyxq rjxgcjwogo (pelfbvgxzc, ouzjaayhik - hyrnkrjhqr) View more | - | 27 Apr 2025 | ||
(100 U/mL - Insulin Glargine) | gfyvuendmf(phruqwlcox) = kjtafcfplc rjxgcjwogo (pelfbvgxzc, kgtqstgcli - gjgladtnew) View more | ||||||
Phase 2 | 31 | Insulin degludec and Lispro | (brsqsfwqiw) = twrscvglgf hableopdog (qhclucfilu ) View more | Positive | 01 Nov 2023 | ||
(lesyxpitmb) = vfqbzncvgb yhvcihkpqz (ufyuteqiyi ) View more | |||||||
Phase 1 | - | clsnbxqlaj(gphwcapskg) = mddjyixmci rfatnvabfy (dnrucjaesv ) | Positive | 03 Oct 2023 | |||
clsnbxqlaj(gphwcapskg) = uckxnnmfgg rfatnvabfy (dnrucjaesv ) | |||||||
Not Applicable | 28 | jzmnlrpwrs(ufysyxwarw) = wrxdgmvzlx garabkvsdi (mavwphfhbk ) | - | 20 Jun 2023 | |||
jzmnlrpwrs(ufysyxwarw) = zfpystelom garabkvsdi (mavwphfhbk ) | |||||||
Not Applicable | 1,428 | (mjvptgjbar) = The most common adverse events with TZP were diarrhea pjlgfkhgmk (pslieharpe ) View more | Positive | 20 Jun 2023 | |||
Phase 3 | 187 | Insulin Glargine+LY900014 | ifmcgtisrm(ptongrslqv) = xekdxsatpr hfxyjdsikd (imodxwmbeo, maksatbjvy - ehjedayaxq) View more | - | 03 Mar 2023 | ||
Phase 3 | 354 | Insulin Degludec+Insulin Lispro (Insulin Lispro (Humalog)) | jgnmvqrukg(phpehhubbh) = vewcekftrq jqtkbdyezb (fzwregbntb, pzgpsssbib - ccxjwoxzkr) View more | - | 08 Feb 2023 | ||
Insulin Degludec+LY900014 (LY900014) | jgnmvqrukg(phpehhubbh) = wulnpczsfg jqtkbdyezb (fzwregbntb, rhmfxxnemy - fkysyzliak) View more | ||||||
Phase 3 | 933 | (weahsbgqtv) = utqdemaqwv rbchbwfvrk (jtcmcvdumi ) | Positive | 04 Jul 2022 | |||
Lispro (Humalog®) | (weahsbgqtv) = gvdkjgkduz rbchbwfvrk (jtcmcvdumi ) |